Acute Renal Colic
Conditions
Interventions
Trial Group:Intramuscular ketorolac tromethamine 30mg + acupuncture at Zulinqi point (retained for 30min)
if pain remains unrelieved within 2h and VAS > 8, administer additional intramuscular pethidine hydrochloride 0.05g
Control Group:Intramuscular ketorolac tromethamine 30mg
Sponsors
Beijing University of Chinese Medicine Fangshan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years; 2.Diagnosed with ureteral stones and presenting with urolithiasis-related pain; 3. Pain Visual Analogue Scale (VAS) score = 5 points; 4. Ureteral stone size = 5 mm (criteria for potential spontaneous passage); 5. Informed consent obtained from the patient or legal representative, with a signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiac, hepatic, or renal dysfunction; 2.Patients who have taken or been administered analgesics or antispasmodics orally or by injection within 6 hours prior to the visit, or who are currently participating in other clinical trials; 3. Women who are pregnant or breastfeeding; 4. Patients with a history of needle fainting or fear of acupuncture, or those with local skin conditions at the acupuncture site such as infection, ulceration, tumor, or edema; 5. Patients allergic to Ketorolac Tromethamine Injection; 6. Patients currently participating in other drug clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) Pain Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to Pain Relief and Recurrence Time;Efficacy Evaluation of Complications;Frequency of Pain Episodes; | — |
Countries
China
Contacts
Public ContactLiu Heng
Beijing University of Chinese Medicine Fangshan Hospital
Outcome results
None listed